Repurposing Disulfiram as an Anti-Obesity Drug: Treating and Preventing Obesity in High-Fat-Fed Rats

References

• Masters RK, Reither EN, Powers DA, Yang YC, Burger AE, Link BG. The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health. 2013;103(10):1895–1901. doi:10.2105/AJPH.2013.301379
   PubMed Web of Science ®Google Scholar
• World Health Organization. Obesity and overweight fact sheet. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed May 17, 2017.
   Google Scholar
• Haslam DW, James WP. Obesity. Lancet. 2005;366(9492):1197–1209. doi:10.1016/S0140-6736(05)67483-1
   PubMed Web of Science ®Google Scholar
• Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635–643. doi:10.1038/35007508
   PubMed Web of Science ®Google Scholar
• Dodson MV, Boudina S, Albrecht E, et al. A long journey to effective obesity treatments: is there light at the end of the tunnel? Exp Biol Med. 2013;238(5):491–501. doi:10.1177/1535370213477603
   Google Scholar
• Frood S, Johnston LM, Matteson CL, Finegood DT. Obesity, complexity, and the role of the health system. Curr Obes Rep. 2013;2(4):320–326. doi:10.1007/s13679-013-0072-9
   PubMedGoogle Scholar
• Omran Z. Obesity: current treatment and future horizons. Mini Rev Med Chem. 2017;17(1):51–61. doi:10.2174/1389557516666160617100328
   PubMedGoogle Scholar
• Belviq, Belviq XR (lorcaserin) by Eisai: drug Safety Communication - FDA Requests Withdrawal of Weight-Loss Drug. Available from: https://www.fda.gov/safety/medical-product-safety-information/belviq-belviq-xr-lorcaserin-eisai-drug-safety-communication-fda-requests-withdrawal-weight-loss-drug. Acessed Mar 16, 2020.
   Google Scholar
• Roberts CA, Christiansen P, Halford JCG. Pharmaceutical approaches to weight management: behavioural mechanisms of action. Curr Opin Physiol. 2019;12:26–32. doi:10.1016/j.cophys.2019.04.017
   Google Scholar
• Pushpakom S, Iorio F, Eyers PA, et al. Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov. 2019;18(1):41–58. doi:10.1038/nrd.2018.168
   PubMed Web of Science ®Google Scholar
• Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3(8):673–683. doi:10.1038/nrd1468
   PubMed Web of Science ®Google Scholar
• Nosengo N. Can you teach old drugs new tricks? Nature. 2016;534(7607):314–316. doi:10.1038/534314a
   PubMed Web of Science ®Google Scholar
• Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med. 2020. doi:10.1056/NEJMoa2001282
   Web of Science ®Google Scholar
• Gautret P, Lagier JC, Parola P. et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949. doi:10.1016/j.ijantimicag.2020.105949
   PubMed Web of Science ®Google Scholar
• Bell RG, Smith HW. Preliminary report on clinical trials of antabuse. Can Med Assoc J. 1949;60(3):286–288.
   PubMedGoogle Scholar
• Yang Q, Yao Y, Li K, et al. An updated review on disulfiram: molecular targets and strategies for cancer treatment. Curr Pharm Des. 2019;25(30):3248–3256. doi:10.2174/1381612825666190816233755
   PubMedGoogle Scholar
• Lee SA, Elliott JH, McMahon J, et al. Population pharmacokinetics and pharmacodynamics of disulfiram on inducing latent HIV-1 transcription in a Phase IIb trial. Clin Pharmacol Ther. 2019;105(3):692–702. doi:10.1002/cpt.1220
   PubMed Web of Science ®Google Scholar
• Rasmussen TA, Sogaard OS. Clinical Interventions in HIV cure research. Adv Exp Med Biol. 2018;1075:285–318.
   PubMed Web of Science ®Google Scholar
• Liegner KB. Disulfiram (Tetraethylthiuram Disulfide) in the treatment of lyme disease and babesiosis: report of experience in three cases. Antibiotics (Basel). 2019;8:2.
   Google Scholar
• Moore SA, Baker HM, Blythe TJ, Kitson KE, Kitson TM, Baker EN. Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases. Structure. 1998;6(12):1541–1551. doi:10.1016/S0969-2126(98)00152-X
   PubMed Web of Science ®Google Scholar
• Ross AC. Overview of retinoid metabolism. J Nutr. 1993;123(2 Suppl):346–350. doi:10.1093/jn/123.suppl_2.346
   PubMedGoogle Scholar
• Duester G, Mic FA, Molotkov A. Cytosolic retinoid dehydrogenases govern ubiquitous metabolism of retinol to retinaldehyde followed by tissue-specific metabolism to retinoic acid. Chem Biol Interact. 2003;143–144:201–210. doi:10.1016/S0009-2797(02)00204-1
   PubMed Web of Science ®Google Scholar
• Kiefer FW, Vernochet C, O’Brien P, et al. Retinaldehyde dehydrogenase 1 regulates a thermogenic program in white adipose tissue. Nat Med. 2012;18(6):918–925. doi:10.1038/nm.2757
   PubMed Web of Science ®Google Scholar
• Ziouzenkova O, Orasanu G, Sharlach M, et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med. 2007;13(6):695–702. doi:10.1038/nm1587
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang X, Maiseyeu A, et al. The prolonged survival of fibroblasts with forced lipid catabolism in visceral fat following encapsulation in alginate-poly-L-lysine. Biomaterials. 2012;33(22):5638–5649. doi:10.1016/j.biomaterials.2012.04.035
   PubMedGoogle Scholar
• Xu L, Shen Q, Mao Z, Lee LJ, Ziouzenkova O. Encapsulation thermogenic preadipocytes for transplantation into adipose tissue depots. J Vis Exp. 2015;100:e52806.
   Google Scholar
• Gilor C, Yang K, Lee A, et al. Thermogenic crosstalk occurs between adipocytes from different species. Sci Rep. 2019;9(1):15177. doi:10.1038/s41598-019-50628-9
   PubMedGoogle Scholar
• Fan X, Molotkov A, Manabe S, et al. Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol Cell Biol. 2003;23(13):4637–4648. doi:10.1128/MCB.23.13.4637-4648.2003
   PubMed Web of Science ®Google Scholar
• Lin YS, Han CH, Lin SY, Hou WC. Synthesized peptides from yam dioscorin hydrolysis in silico exhibit dipeptidyl peptidase-IV inhibitory activities and oral glucose tolerance improvements in normal mice. J Agric Food Chem. 2016;64(33):6451–6458. doi:10.1021/acs.jafc.6b02403
   PubMedGoogle Scholar
• Marques C, Meireles M, Norberto S, et al. High-fat diet-induced obesity Rat model: a comparison between Wistar and Sprague-Dawley Rat. Adipocyte. 2016;5(1):11–21. doi:10.1080/21623945.2015.1061723
   PubMed Web of Science ®Google Scholar
• Kiefer FW, Orasanu G, Nallamshetty S, et al. Retinaldehyde dehydrogenase 1 coordinates hepatic gluconeogenesis and lipid metabolism. Endocrinology. 2012;153(7):3089–3099. doi:10.1210/en.2011-2104
   PubMed Web of Science ®Google Scholar
• Silver DF, Ewing JA, Rouse BA, Mueller RA. Responses to Disulfiram in healthy young men; a double-blind study. J Stud Alcohol. 1979;40(11):1003–1013. doi:10.15288/jsa.1979.40.1003
   Google Scholar
• Martensen-Larsen O. Psychotic phenomena provoked by tetraethylthiuram disulfide. Q J Stud Alcohol. 1951;12(2):206–216.
   PubMedGoogle Scholar
• Disulfiram [MAK Value Documentation, 1993]. The MAK‐Collection for Occupational Health and Safety. 166–180.
   Google Scholar
• Sauna ZE, Peng XH, Nandigama K, Tekle S, Ambudkar SV. The molecular basis of the action of disulfiram as a modulator of the multidrug resistance-linked ATP binding cassette transporters MDR1 (ABCB1) and MRP1 (ABCC1). Mol Pharmacol. 2004;65(3):675–684. doi:10.1124/mol.65.3.675
   PubMed Web of Science ®Google Scholar